{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Neurotransmitter disorders",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "不良表型风险",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_levodopa",
          "type": "Drug",
          "label": "Levodopa",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rasagiline",
          "type": "Drug",
          "label": "Rasagiline",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_selegiline",
          "type": "Drug",
          "label": "Selegiline",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_amantadine",
          "type": "Drug",
          "label": "Amantadine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tetrabenazine",
          "type": "Drug",
          "label": "Tetrabenazine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methylphenidate",
          "type": "Drug",
          "label": "Methylphenidate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dextroamphetamine",
          "type": "Drug",
          "label": "Dextroamphetamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_clonidine",
          "type": "Drug",
          "label": "Clonidine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_buspirone",
          "type": "Drug",
          "label": "Buspirone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_aripiprazole",
          "type": "Drug",
          "label": "Aripiprazole",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_desvenlafaxine",
          "type": "Drug",
          "label": "Desvenlafaxine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_atomoxetine",
          "type": "Drug",
          "label": "Atomoxetine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_nt_disorders",
          "type": "Disease",
          "label": "Neurotransmitter disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot1",
          "type": "Target",
          "label": "OffTarget1",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot2",
          "type": "Target",
          "label": "OffTarget2",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp1",
          "type": "Pathway",
          "label": "RiskPathway1",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp2",
          "type": "Pathway",
          "label": "RiskPathway2",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv1",
          "type": "Phenotype",
          "label": "AdversePhenotype1",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv2",
          "type": "Phenotype",
          "label": "AdversePhenotype2",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_levodopa",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "用于多种神经递质疾病的经典药物"
        },
        {
          "source": "drug_rasagiline",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "对帕金森病有良好效果"
        },
        {
          "source": "drug_selegiline",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.78,
          "agent": "Proponent",
          "rationale": "常用于抑郁及帕金森的治疗"
        },
        {
          "source": "drug_amantadine",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.76,
          "agent": "Proponent",
          "rationale": "有助于帕金森症状改善"
        },
        {
          "source": "drug_tetrabenazine",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "用于运动障碍，尤其是亨廷顿病"
        },
        {
          "source": "drug_methylphenidate",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.72,
          "agent": "Proponent",
          "rationale": "用于多动症，影响神经递质"
        },
        {
          "source": "drug_dextroamphetamine",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "用于注意缺陷多动障碍的治疗"
        },
        {
          "source": "drug_clonidine",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "用于抗抑郁及焦虑"
        },
        {
          "source": "drug_buspirone",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.63,
          "agent": "Proponent",
          "rationale": "用于焦虑症的治疗"
        },
        {
          "source": "drug_aripiprazole",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于精神分裂症及双相障碍"
        },
        {
          "source": "drug_desvenlafaxine",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.58,
          "agent": "Proponent",
          "rationale": "抗抑郁药，影响神经递质"
        },
        {
          "source": "drug_atomoxetine",
          "target": "n_nt_disorders",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "用于注意缺陷多动障碍"
        },
        {
          "source": "drug_levodopa",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "drug_rasagiline",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "drug_selegiline",
          "target": "n_ot2",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot1",
          "target": "n_rp1",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_ot2",
          "target": "n_rp2",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp1",
          "target": "n_adv1",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_rp2",
          "target": "n_adv2",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv1",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "n_adv2",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        }
      ],
      "round_index": 4
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [],
          "merge": [],
          "set_weights": [],
          "conflict_hotspots": [
            {
              "topic": "不良表型风险",
              "pro_nodes": [
                "drug_levodopa",
                "drug_rasagiline"
              ],
              "con_nodes": [
                "n_adv1",
                "n_adv2"
              ],
              "note": "若不良作用风险成立，可能抵消疗效"
            }
          ]
        },
        "notes": "已完成安全性压力测试：以高权重 refutes 边连到假设"
      }
    ],
    "unexecuted_actions": [],
    "residual_conflicts": [
      "不良表型与药物适应症潜在冲突"
    ]
  }
}